# Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects

> **NCT01520649** · PHASE1 · COMPLETED · sponsor: **Neuralstem Inc.** · enrollment: 26 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** NSI-189 Phosphate
- **DRUG:** microcrystalline cellulose capsules

## Key facts

- **NCT ID:** NCT01520649
- **Lead sponsor:** Neuralstem Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01520649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01520649, "Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects". Retrieved via AI Analytics 2026-06-21 from https://api.ai-analytics.org/clinical/NCT01520649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*